01 Surgical oncology session 02 Breast cancer: updates surgical management breast and axilla 03 Efficacy and safety of oncoplastic breast conserving surgery vs conventional breast conserving surgery 04 Ovarian cancer: oncological approach new cases 05 Colon cancer peritoneal disease 06 Discussion 10 min 07 Breast cancer session 08 Early TNBC : neoadjuvant and adjuvant updates 09 Approach Her2+ breast cancer brain mets 1st and subsequent lines 10 ADC in MBC her2 low 11 HR+ MBC CDK4 inhibitor 1st line vs 2nd 12 Discussion 10 min 13 GI/GU session 14 Management of mets stage HCC 1st line 15 MSI high colorectal cancer 16 mCRC : later lines 17 Hormone sensitive prostate cancer management updates 18 Approach for Mets Urothelial carcinoma post 1st line immunotherapy-based treatments 19 Discussion 10 min 20 Oncology miscellaneous 21 Lung cancer : neoadjuvant and adjuvant updates 22 Lung cancer : Mets NSCLC EGFR mutated ( 1st and subsequent line ) updates 23 Maintenance therapy in ovarian epithelia cancer 1st line 24 Mets GIST treatment options overview 25 Immunotherapy in mets uterine cancer her2-ve 1st line updates 26 Discussion 10 min
